ACPMP is excited to host "Updates on the Surgical Management of Peritoneal Surface Malignancies" with UPMC Hillman Cancer Center's Dr. Choudry on September 17th, 2020 from 5pm to 6pm Eastern Time via Zoom. This event is free and will be CME accredited. Registration is required. (This event is intended for medical professionals). REGISTER HERE Objectives include: Rational for Cytoreductive Surgery...

"Often uncovered by accident, appendiceal cancers trigger few symptoms until they’re advanced and can be difficult to detect and treat."  Dara Chadwick's article titled "Appendix Cancer: An Elusive Diagnosis" was released yesterday August 26, 2020. The article dives into the peculiarity of an appendix cancer diagnosis and features first hand commentary from our very own ACPMP President, Jerry Lewandowski, a...

The ACPMP Research Foundation is excited to share with everyone our 2019 impact report highlighting how donor funds were used, what ACPMP supported this year and a collective overview of the impact we had as a nonprofit organization. We are committed to financial transparency and want our donors to know how every dollar they donate is spent. Our 2019 IRS...

ACPMP is pleased to announce the RFP is NOW OPEN for our 2020 Grant Cycle. ACPMP will offer two $50,000, 2-year grants for 2020. The 2020 grant timeline is as follows: RFP available: June 22, 2020 Abstract deadline: August 25, 2020 Full proposal invitations: Fall 2020 Full proposal deadline: Fall 2020 Award announcements: December 2020 ACPMP is the leading organization funding promising research worldwide...

We are thrilled to announce that our 14th Annual Appendix Cancer PMP Virtual Walk/Run raised over $90,000 for appendix cancer research and education which is truly incredible. We more than doubled the amount raised at last year's event, thanks to our amazing and generous supporters! Thank you, thank you, thank you!!! We had supporters from all across the US, Canada...

FDA has now approved KEYTRUDA (pembrolizumab) for a second indication based on a tumor biomarker rather than the originating source of the tumor in the body.  Specifically, FDA has approved KEYTRUDA for patients with an unresectable or metastatic solid tumor with a high mutational burden (i.e, 10 or more mutations).  As part of this approval, FDA has also approved Foundation...

We hope you will join us this Father's Day Weekend (June 20th and 21st) for our 14th Annual Appendix Cancer/PMP VIRTUAL Walk/Run! This is our first 100% VIRTUAL walk/run and that means you can participate from ANYWHERE IN THE WORLD! Register to walk, run, hike, bike -- whatever you choose, or make a donation and be entered into the raffle for an...

Beck Schroeder's 8th birthday party looked very similar to how most other kids ring in another year -- Balloons, cake, decorations, and friends. But one thing was noticeably missing, there weren't any birthday gifts in sight. When Beck's 8th birthday was around the corner, he decided to do something different. Beck, from Prior Lake, Minnesota, asked that his friends make...

Unfortunately, rare cancer does not halt in the face of COVID-19. Many of our patients continue to need treatment, surgeries and scans in the wake of this pandemic. Many of our patients are immunocompromised. Fighting a rare disease with no cure is a constant uphill battle. We hope to keep up our momentum towards finding a cure by funding promising...

Join the Society of Surgical Oncology (SSO) on Monday, May 4, at 5 PM CDT or 6 PM EST for a virtual tumor board to discuss the current state of surgery for peritoneal surface disease. Click here to register and join: http://SSO.informz.net/z/cjUucD9taT03OTE0NTY0JnA9MSZ1PTc4OTM4MjI2NSZsaT02NTMxOTUzMA/index.html  Panelists from across the country will provide an update on the current state of COVID-19 and cover current practices in the...